Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Nov;52(11):1234-1235.
doi: 10.1016/j.dld.2020.06.007. Epub 2020 Jun 13.

Low frequency of COVID-19 in inflammatory bowel diseases

Irene Marafini  1 , Silvia Salvatori  1 , Giorgia Sena  1 , Emma Calabrese  1 , Livia Biancone  1 , Giovanni Monteleone  2
Affiliations
Comment

Low frequency of COVID-19 in inflammatory bowel diseases

Irene Marafini et al. Dig Liver Dis. 2020 Nov.
No abstract available

Keywords: Coronavirus; Crohn's disease;Ulcerative colitis; Sars-cov-2.

PubMed Disclaimer

Conflict of interest statement

Declaration of CompetingInterest Giovanni Monteleone served as an advisory board member for AbbVie. Emma Calabrese has received fees from ABBVIE, TAKEDA and JANSSEN. The other authors have no conflict of interest.

Comment on

References

    1. Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., Niu P., Zhan F., Ma X., Wang D., Xu W., Wu G., Gao G.F., Tan W. China novel coronavirus investigating and research team. a novel Coronavirus from patients with Pneumonia in China, 2019. N Engl J Med. 2020;382:727–733. - PMC - PubMed
    1. Dulai P.S., Thompson K.D., Blunt H.B., Dubinsky M.C., Siegel C.A. Risks of serious infection or lymphoma with anti-tumor necrosis factor therapy for pediatric inflammatory bowel disease: a systematic review. Clin Gastroenterol Hepatol. 2014;12:1443–1451. - PubMed
    1. Hoffmann M., Kleine-Weber H., Schroeder S., Krüger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., Müller M.A., Drosten C., Pöhlmann S. SARS-CoV-2 Cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020 doi: 10.1016/j.cell.2020.02.052. Mar 4. pii: S0092-8674(20)30229-4. - DOI - PMC - PubMed
    1. Harmer D., Gilbert M., Borman R. Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett. 2002;532:107–110. - PubMed
    1. Wang W., Xu Y., Gao R., Lu R., Han K., Wu G., Tan W. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA. 2020 doi: 10.1001/jama.2020.3786. Mar 11. - DOI - PMC - PubMed